ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastrointestinal Stromal Tumor (GIST) Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-30D9206
Home | Market Reports | Health| Health Conditions| Cancer
Global Gastrointestinal Stromal Tumor GIST Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Research Report 2025

Code: QYRE-Auto-30D9206
Report
September 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ariad Pharmaceuticals Inc
Arog Pharmaceuticals Inc
Array BioPharma Inc
Astex Pharmaceuticals Inc
Blueprint Medicines Corporation
Boston Biomedical Inc
Calithera Biosciences Inc
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals LLC
F Hoffmann La Roche Ltd
Horizon Pharma Plc
Immunicum
Jiangsu Hengrui Medicine Co Ltd
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S r l
Novartis
Omeros Corporation

Gastrointestinal Stromal Tumor (GIST) Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gastrointestinal Stromal Tumor (GIST) Drug Market

Gastrointestinal Stromal Tumor (GIST) Drug Market

The global market for Gastrointestinal Stromal Tumor (GIST) Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Stromal Tumor (GIST) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Stromal Tumor (GIST) Drug.
The Gastrointestinal Stromal Tumor (GIST) Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal Stromal Tumor (GIST) Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Stromal Tumor (GIST) Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gastrointestinal Stromal Tumor (GIST) Drug Market Report

Report Metric Details
Report Name Gastrointestinal Stromal Tumor (GIST) Drug Market
CAGR 5%
Segment by Type
Segment by Application
  • Clinic
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ariad Pharmaceuticals, Inc., Arog Pharmaceuticals, Inc., Array BioPharma Inc., Astex Pharmaceuticals, Inc., Blueprint Medicines Corporation, Boston Biomedical, Inc., Calithera Biosciences, Inc., Chipscreen Biosciences Ltd, Deciphera Pharmaceuticals, LLC, F. Hoffmann-La Roche Ltd., Horizon Pharma Plc, Immunicum AB, Jiangsu Hengrui Medicine Co., Ltd., Kolltan Pharmaceuticals, Inc., Natco Pharma Limited, Nerviano Medical Sciences S.r.l., Novartis AG, Omeros Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gastrointestinal Stromal Tumor (GIST) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gastrointestinal Stromal Tumor (GIST) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gastrointestinal Stromal Tumor (GIST) Drug Market report?

Ans: The main players in the Gastrointestinal Stromal Tumor (GIST) Drug Market are Ariad Pharmaceuticals, Inc., Arog Pharmaceuticals, Inc., Array BioPharma Inc., Astex Pharmaceuticals, Inc., Blueprint Medicines Corporation, Boston Biomedical, Inc., Calithera Biosciences, Inc., Chipscreen Biosciences Ltd, Deciphera Pharmaceuticals, LLC, F. Hoffmann-La Roche Ltd., Horizon Pharma Plc, Immunicum AB, Jiangsu Hengrui Medicine Co., Ltd., Kolltan Pharmaceuticals, Inc., Natco Pharma Limited, Nerviano Medical Sciences S.r.l., Novartis AG, Omeros Corporation

What are the Application segmentation covered in the Gastrointestinal Stromal Tumor (GIST) Drug Market report?

Ans: The Applications covered in the Gastrointestinal Stromal Tumor (GIST) Drug Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Gastrointestinal Stromal Tumor (GIST) Drug Market report?

Ans: The Types covered in the Gastrointestinal Stromal Tumor (GIST) Drug Market report are Amcasertib, Anagrelide hydrochloride CR, APG-1351, Binimetinib, Others

Recommended Reports

Cancer Therapy Drugs

Gastrointestinal Diseases

Cancer Diagnosis

1 Gastrointestinal Stromal Tumor (GIST) Drug Market Overview
1.1 Product Definition
1.2 Gastrointestinal Stromal Tumor (GIST) Drug by Type
1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Amcasertib
1.2.3 Anagrelide hydrochloride CR
1.2.4 APG-1351
1.2.5 Binimetinib
1.2.6 Others
1.3 Gastrointestinal Stromal Tumor (GIST) Drug by Application
1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Estimates and Forecasts
1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2020-2031
1.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales 2020-2031
1.4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Manufacturers
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gastrointestinal Stromal Tumor (GIST) Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug, Product Type & Application
2.7 Global Key Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug, Date of Enter into This Industry
2.8 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
2.8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastrointestinal Stromal Tumor (GIST) Drug Players Market Share by Revenue
2.8.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Scenario by Region
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region: 2020-2031
3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region: 2020-2025
3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region: 2026-2031
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region: 2020-2031
3.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region: 2020-2025
3.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region: 2026-2031
3.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country
3.4.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2031)
3.4.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country
3.5.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2031)
3.5.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country
3.7.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2031)
3.7.3 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2020-2031)
4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2020-2025)
4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2026-2031)
4.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2020-2031)
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2020-2031)
4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2020-2025)
4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2026-2031)
4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2020-2031)
4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2020-2031)
5.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2020-2025)
5.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2026-2031)
5.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2020-2031)
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2020-2031)
5.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2020-2025)
5.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2026-2031)
5.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2020-2031)
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ariad Pharmaceuticals, Inc.
6.1.1 Ariad Pharmaceuticals, Inc. Company Information
6.1.2 Ariad Pharmaceuticals, Inc. Description and Business Overview
6.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.1.5 Ariad Pharmaceuticals, Inc. Recent Developments/Updates
6.2 Arog Pharmaceuticals, Inc.
6.2.1 Arog Pharmaceuticals, Inc. Company Information
6.2.2 Arog Pharmaceuticals, Inc. Description and Business Overview
6.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.2.5 Arog Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Array BioPharma Inc.
6.3.1 Array BioPharma Inc. Company Information
6.3.2 Array BioPharma Inc. Description and Business Overview
6.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.3.5 Array BioPharma Inc. Recent Developments/Updates
6.4 Astex Pharmaceuticals, Inc.
6.4.1 Astex Pharmaceuticals, Inc. Company Information
6.4.2 Astex Pharmaceuticals, Inc. Description and Business Overview
6.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.4.5 Astex Pharmaceuticals, Inc. Recent Developments/Updates
6.5 Blueprint Medicines Corporation
6.5.1 Blueprint Medicines Corporation Company Information
6.5.2 Blueprint Medicines Corporation Description and Business Overview
6.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.5.5 Blueprint Medicines Corporation Recent Developments/Updates
6.6 Boston Biomedical, Inc.
6.6.1 Boston Biomedical, Inc. Company Information
6.6.2 Boston Biomedical, Inc. Description and Business Overview
6.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.6.5 Boston Biomedical, Inc. Recent Developments/Updates
6.7 Calithera Biosciences, Inc.
6.7.1 Calithera Biosciences, Inc. Company Information
6.7.2 Calithera Biosciences, Inc. Description and Business Overview
6.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.7.5 Calithera Biosciences, Inc. Recent Developments/Updates
6.8 Chipscreen Biosciences Ltd
6.8.1 Chipscreen Biosciences Ltd Company Information
6.8.2 Chipscreen Biosciences Ltd Description and Business Overview
6.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.8.5 Chipscreen Biosciences Ltd Recent Developments/Updates
6.9 Deciphera Pharmaceuticals, LLC
6.9.1 Deciphera Pharmaceuticals, LLC Company Information
6.9.2 Deciphera Pharmaceuticals, LLC Description and Business Overview
6.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.9.5 Deciphera Pharmaceuticals, LLC Recent Developments/Updates
6.10 F. Hoffmann-La Roche Ltd.
6.10.1 F. Hoffmann-La Roche Ltd. Company Information
6.10.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.10.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.11 Horizon Pharma Plc
6.11.1 Horizon Pharma Plc Company Information
6.11.2 Horizon Pharma Plc Description and Business Overview
6.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.11.5 Horizon Pharma Plc Recent Developments/Updates
6.12 Immunicum AB
6.12.1 Immunicum AB Company Information
6.12.2 Immunicum AB Description and Business Overview
6.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.12.5 Immunicum AB Recent Developments/Updates
6.13 Jiangsu Hengrui Medicine Co., Ltd.
6.13.1 Jiangsu Hengrui Medicine Co., Ltd. Company Information
6.13.2 Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
6.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
6.14 Kolltan Pharmaceuticals, Inc.
6.14.1 Kolltan Pharmaceuticals, Inc. Company Information
6.14.2 Kolltan Pharmaceuticals, Inc. Description and Business Overview
6.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
6.15 Natco Pharma Limited
6.15.1 Natco Pharma Limited Company Information
6.15.2 Natco Pharma Limited Description and Business Overview
6.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.15.5 Natco Pharma Limited Recent Developments/Updates
6.16 Nerviano Medical Sciences S.r.l.
6.16.1 Nerviano Medical Sciences S.r.l. Company Information
6.16.2 Nerviano Medical Sciences S.r.l. Description and Business Overview
6.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.16.5 Nerviano Medical Sciences S.r.l. Recent Developments/Updates
6.17 Novartis AG
6.17.1 Novartis AG Company Information
6.17.2 Novartis AG Description and Business Overview
6.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.17.5 Novartis AG Recent Developments/Updates
6.18 Omeros Corporation
6.18.1 Omeros Corporation Company Information
6.18.2 Omeros Corporation Description and Business Overview
6.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.18.5 Omeros Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Chain Analysis
7.2 Gastrointestinal Stromal Tumor (GIST) Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastrointestinal Stromal Tumor (GIST) Drug Production Mode & Process Analysis
7.4 Gastrointestinal Stromal Tumor (GIST) Drug Sales and Marketing
7.4.1 Gastrointestinal Stromal Tumor (GIST) Drug Sales Channels
7.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
7.5 Gastrointestinal Stromal Tumor (GIST) Drug Customer Analysis
8 Gastrointestinal Stromal Tumor (GIST) Drug Market Dynamics
8.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends
8.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
8.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
8.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Ariad Pharmaceuticals Inc
Arog Pharmaceuticals Inc
Array BioPharma Inc
Astex Pharmaceuticals Inc
Blueprint Medicines Corporation
Boston Biomedical Inc
Calithera Biosciences Inc
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals LLC
F Hoffmann La Roche Ltd
Horizon Pharma Plc
Immunicum
Jiangsu Hengrui Medicine Co Ltd
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S r l
Novartis
Omeros Corporation
List of Tables
 Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gastrointestinal Stromal Tumor (GIST) Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gastrointestinal Stromal Tumor (GIST) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Ariad Pharmaceuticals, Inc. Company Information
 Table 71. Ariad Pharmaceuticals, Inc. Description and Business Overview
 Table 72. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 74. Ariad Pharmaceuticals, Inc. Recent Developments/Updates
 Table 75. Arog Pharmaceuticals, Inc. Company Information
 Table 76. Arog Pharmaceuticals, Inc. Description and Business Overview
 Table 77. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 79. Arog Pharmaceuticals, Inc. Recent Developments/Updates
 Table 80. Array BioPharma Inc. Company Information
 Table 81. Array BioPharma Inc. Description and Business Overview
 Table 82. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 84. Array BioPharma Inc. Recent Developments/Updates
 Table 85. Astex Pharmaceuticals, Inc. Company Information
 Table 86. Astex Pharmaceuticals, Inc. Description and Business Overview
 Table 87. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 89. Astex Pharmaceuticals, Inc. Recent Developments/Updates
 Table 90. Blueprint Medicines Corporation Company Information
 Table 91. Blueprint Medicines Corporation Description and Business Overview
 Table 92. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 94. Blueprint Medicines Corporation Recent Developments/Updates
 Table 95. Boston Biomedical, Inc. Company Information
 Table 96. Boston Biomedical, Inc. Description and Business Overview
 Table 97. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 99. Boston Biomedical, Inc. Recent Developments/Updates
 Table 100. Calithera Biosciences, Inc. Company Information
 Table 101. Calithera Biosciences, Inc. Description and Business Overview
 Table 102. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 104. Calithera Biosciences, Inc. Recent Developments/Updates
 Table 105. Chipscreen Biosciences Ltd Company Information
 Table 106. Chipscreen Biosciences Ltd Description and Business Overview
 Table 107. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 109. Chipscreen Biosciences Ltd Recent Developments/Updates
 Table 110. Deciphera Pharmaceuticals, LLC Company Information
 Table 111. Deciphera Pharmaceuticals, LLC Description and Business Overview
 Table 112. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 114. Deciphera Pharmaceuticals, LLC Recent Developments/Updates
 Table 115. F. Hoffmann-La Roche Ltd. Company Information
 Table 116. F. Hoffmann-La Roche Ltd. Description and Business Overview
 Table 117. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 119. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
 Table 120. Horizon Pharma Plc Company Information
 Table 121. Horizon Pharma Plc Description and Business Overview
 Table 122. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 124. Horizon Pharma Plc Recent Developments/Updates
 Table 125. Immunicum AB Company Information
 Table 126. Immunicum AB Description and Business Overview
 Table 127. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 129. Immunicum AB Recent Developments/Updates
 Table 130. Jiangsu Hengrui Medicine Co., Ltd. Company Information
 Table 131. Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
 Table 132. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 134. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
 Table 135. Kolltan Pharmaceuticals, Inc. Company Information
 Table 136. Kolltan Pharmaceuticals, Inc. Description and Business Overview
 Table 137. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 139. Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
 Table 140. Natco Pharma Limited Company Information
 Table 141. Natco Pharma Limited Description and Business Overview
 Table 142. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 144. Natco Pharma Limited Recent Developments/Updates
 Table 145. Nerviano Medical Sciences S.r.l. Company Information
 Table 146. Nerviano Medical Sciences S.r.l. Description and Business Overview
 Table 147. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 148. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 149. Nerviano Medical Sciences S.r.l. Recent Developments/Updates
 Table 150. Novartis AG Company Information
 Table 151. Novartis AG Description and Business Overview
 Table 152. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 153. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 154. Novartis AG Recent Developments/Updates
 Table 155. Omeros Corporation Company Information
 Table 156. Omeros Corporation Description and Business Overview
 Table 157. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 158. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product
 Table 159. Omeros Corporation Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
 Table 163. Gastrointestinal Stromal Tumor (GIST) Drug Customers List
 Table 164. Gastrointestinal Stromal Tumor (GIST) Drug Market Trends
 Table 165. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
 Table 166. Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
 Table 167. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gastrointestinal Stromal Tumor (GIST) Drug
 Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type: 2024 & 2031
 Figure 4. Amcasertib Product Picture
 Figure 5. Anagrelide hydrochloride CR Product Picture
 Figure 6. APG-1351 Product Picture
 Figure 7. Binimetinib Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application: 2024 & 2031
 Figure 11. Clinic
 Figure 12. Hospital
 Figure 13. Others
 Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (2020-2031) & (K Pcs)
 Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered
 Figure 19. Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Manufacturers in 2024
 Figure 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Gastrointestinal Stromal Tumor (GIST) Drug Players: Market Share by Revenue in Gastrointestinal Stromal Tumor (GIST) Drug in 2024
 Figure 22. Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2020-2031)
 Figure 25. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2020-2031)
 Figure 29. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2020-2031)
 Figure 37. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2020-2031)
 Figure 59. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2020-2031)
 Figure 62. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Gastrointestinal Stromal Tumor (GIST) Drug Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Gastrointestinal Stromal Tumors Therapeutics Market Research Report 2025
Global Gastrointestinal Rare Diseases Treatment Market Research Report 2025
Solid Tumor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastric Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Research Report 2024
Global Peptic Ulcers Treatment Market Research Report 2024
Global CGT Drugs Market Research Report 2025
Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stomach Cancer Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Keloid Treatment Market Research Report 2024
Inflammatory Bowel Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastroesophageal Reflux Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acute Gastritis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Screening Test Kit Market
Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inflammatory Bowel Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastro Esophageal Reflux Disease GERD Drug Market Research Report 2025
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intratumoral Cancer Therapies Market Research Report 2025

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions